Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, M.D., William Jacot, M.D., Ph.D., Toshinari Yamashita, M.D., Ph.D., Joohyuk Sohn, M.D. https://orcid.org/0000-0002-2303-2764, Maria Vidal, M.D., Ph.D., Eriko Tokunaga, M.D., Ph.D., Junji Tsurutani, M.D., Ph.D., +31 , for the DESTINY-Breast04 Trial Investigators* For many people, a breast cancer diagnosis is quickly followed by a secondContinueContinue reading “A New Category of Breast Cancer Is Changing Treatment Options”
Category Archives: Clinical Trials
Replacing Lost Neurons in Parkinson’s Disease: Early Clinical Results of Bemdaneprocel
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease V. Tabar, H. Sarva, A. M. Lozano, A. Fasano, S. K. Kalia, K. K. H. Yu, C. Brennan, Y. Ma, S. Peng, D. Eidelberg, M. Tomishima, S. Irion, W. Stemple, N. Abid, A. Lampron, L. Studer & C. Henchcliffe For millions of people living withContinueContinue reading “Replacing Lost Neurons in Parkinson’s Disease: Early Clinical Results of Bemdaneprocel”
Scientists Arm Immune Cells To Combat Aggressive Brain Tumors: Early Trial Results
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial Christine E. Brown, Jonathan C. Hibbard, Darya Alizadeh, M. Suzette Blanchard, Heini M. Natri, Dongrui Wang, Julie R. Ostberg, Brenda Aguilar, Jamie R. Wagner, Jinny A. Paul, Renate Starr, Robyn A. Wong, Wuyang Chen, Noah Shulkin, Maryam Aftabizadeh, Aleksandr Filippov, AmmarContinueContinue reading “Scientists Arm Immune Cells To Combat Aggressive Brain Tumors: Early Trial Results”